Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-κB activation

Immunology Letters

Volumn 121, Issue 2, 2008, Pages 127-133

  Feng, Dechun ^a   Mei, Yunhua ^b   Wang, Ying ^b   Zhang, Bianhong ^c   Wang, Chen ^c   Xu, Lingyun ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Concanavalin A induced hepatitis; NF B; Tetrandrine

Indexed keywords

ALANINE AMINOTRANSFERASE; CHEMOKINE; CONCANAVALIN A; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; TETRANDRINE; TUMOR NECROSIS FACTOR ALPHA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HEPATITIS; INFLAMMATION; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BENZYLISOQUINOLINES; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CXCL10; CONCANAVALIN A; CYTOKINES; DRUGS, CHINESE HERBAL; ENZYME INDUCTION; HEPATITIS, ANIMAL; HEPATOCYTES; I-KAPPA B KINASE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STEPHANIA TETRANDRA; TRANSCRIPTIONAL ACTIVATION;

EID: 57449099845     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.10.001     Document Type: Article

References (38)

1. Ho L.J., and Lai J.H. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr Drug Metab 5 (2004) 181-192
2. Xie Q.M., Tang H.F., Chen J.Q., and Bian R.L. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin 23 (2002) 1107-1113
3. Lai J.H. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin 23 (2002) 1093-1101
4. Rao M.R. Effects of tetrandrine on cardiac and vascular remodeling. Acta Pharmacol Sin 23 (2002) 1075-1085
5. Exley R., Iturriaga-Vasquez P., Lukas R.J., Sher E., Cassels B.K., and Bermudez I. Evaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptors. Br J Pharmacol 146 (2005) 15-24
6. Wang G., Lemos J.R., and Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25 (2004) 120-123
7. Meng L.H., Zhang H., Hayward L., Takemura H., Shao R.G., and Pommier Y. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 64 (2004) 9086-9092
8. Oh S.H., and Lee B.H. Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release. Biochem Pharmacol 66 (2003) 725-731
9. Lai J.H., Ho L.J., Kwan C.Y., Chang D.M., and Lee T.C. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation 68 (1999) 1383-1392
10. Ferrante A., Seow W.K., Rowan-Kelly B., and Thong Y.H. Tetrandrine a plant alkaloid, inhibits the production of tumour necrosis factor-alpha (cachectin) hy human monocytes. Clin Exp Immunol 80 (1990) 232-235
11. Chen F., Sun S., Kuhn D.C., Lu Y., Gaydos L.J., Shi X., et al. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages. Biochem Biophys Res Commun 231 (1997) 99-102
12. Ho L.J., Juan T.Y., Chao P., Wu W.L., Chang D.M., Chang S.Y., et al. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell. Br J Pharmacol 143 (2004) 919-927
13. Ho L.J., Chang D.M., Lee T.C., Chang M.L., and Lai J.H. Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells. Eur J Pharmacol 367 (1999) 389-398
14. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191 (2000) 105-114
15. Tiegs G., Hentschel J., and Wendel A.A. T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90 (1992) 196-203
16. Miyazawa Y., Tsutsui H., Mizuhara H., Fujiwara H., and Kaneda K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology 27 (1998) 497-506
17. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179 (1994) 1529-1537
18. Gantner F., Leist M., Lohse A.W., Germann P.G., and Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21 (1995) 190-198
19. Sass G., Heinlein S., Agli A., Bang R., Schumann J., and Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19 (2002) 115-120
20. Kusters S., Gantner F., Kunstle G., and Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111 (1996) 462-471
21. Mizuhara H., Uno M., Seki N., Yamashita M., Yamaoka M., Ogawa T., et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23 (1996) 1608-1615
22. Moreno C., Gustot T., Nicaise C., Quertinmont E., Nagy N., Parmentier M., et al. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 42 (2005) 854-862
23. Itoh Y., Morita A., Nishioji K., Fujii H., Nakamura H., Kirishima T., et al. Time course profile and cell-type-specific production of monokine induced by interferon-gamma in Concanavalin A-induced hepatic injury in mice: comparative study with interferon-inducible protein-10. Scand J Gastroenterol 36 (2001) 1344-1351
24. Ajuebor M.N., Hogaboam C.M., Le T., and Swain M.G. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. J Immunol 170 (2003) 5252-5259
25. Moriya T., Fukatsu K., Maeshima Y., Ikezawa F., Ueno C., Kang W., et al. Nutritional route affects ERK phosphorylation and cytokine production in hepatic mononuclear cells. Ann Surg 245 (2007) 642-650
26. Nagaki M., Naiki T., Brenner D.A., Osawa Y., Imose M., Hayashi H., et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology 32 (2000) 1272-1279
27. Streetz K., Fregien B., Plumpe J., Korber K., Kubicka S., Sass G., et al. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in ConA-induced liver failure. J Immunol 167 (2001) 514-523
28. Nakamura K., Okada M., Yoneda M., Takamoto S., Nakade Y., Tamori K., et al. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 35 (2001) 217-224
29. Ajuebor M.N., Hogaboam C.M., Le T., Proudfoot A.E., and Swain M.G. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 34 (2004) 2907-2918
30. Kondo Y., Takano F., and Hojo H. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem Pharmacol 46 (1993) 1887-1892
31. Xiao J.G., and Chiou G.C. Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats. J Ocul Pharmacol Ther 12 (1996) 323-329
32. Kondo Y., Takano F., and Hojo H. Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bisbenzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol 46 (1993) 1861-1863
33. Ksontini R., Colagiovanni D.B., Josephs M.D., Edwards III C.K., Tannahill C.L., Solorzano C.C., et al. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol 160 (1998) 4082-4089
34. Kusters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Kunstle G., et al. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27 (1997) 2870-2875
35. Neish A.S., Read M.A., Thanos D., Pine R., Maniatis T., and Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15 (1995) 2558-2569
36. Hong F., Jaruga B., Kim W.H., Radaeva S., El-Assal O.N., Tian Z., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110 (2002) 1503-1513
37. Tamaru M., Nishioji K., Kobayashi Y., Watanabe Y., Itoh Y., Okanoue T., et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine 12 (2000) 299-308
38. Nicoletti F., Di Marco R., Zaccone P., Salvaggio A., Magro G., Bendtzen K., et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 32 (2000) 728-733